Metabolic adaptations in prostate cancer

被引:8
|
作者
Pujana-Vaquerizo, Mikel [1 ,2 ]
Bozal-Basterra, Laura [1 ]
Carracedo, Arkaitz [1 ,2 ,3 ,4 ,5 ]
机构
[1] Basque Res & Technol Alliance BRTA, Ctr Cooperat Res Biosci CIC bioGUNE, Bizkaia Technol Pk,Bldg 800, Derio 48160, Spain
[2] Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain
[3] Biobizkaia Hlth Res Inst, CIC BioGUNE Basurto, Traslat Prostate Canc Res Lab, Bilbao, Spain
[4] Ikerbasque, Basque Fdn Sci, Bilbao, Spain
[5] Univ Basque Country UPV EHU, Biochem & Mol Biol Dept, Leioa, Spain
基金
欧盟地平线“2020”; 欧洲研究理事会;
关键词
GLYCINE-N-METHYLTRANSFERASE; ONE-CARBON METABOLISM; FATTY-ACID SYNTHASE; T-CELL METABOLISM; BODY-MASS INDEX; ANDROGEN RECEPTOR; CASTRATION-RESISTANT; ORNITHINE-DECARBOXYLASE; TUMOR MICROENVIRONMENT; LIPID-METABOLISM;
D O I
10.1038/s41416-024-02762-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate cancer is one of the most commonly diagnosed cancers in men and is a major cause of cancer-related deaths worldwide. Among the molecular processes that contribute to this disease, the weight of metabolism has been placed under the limelight in recent years. Tumours exhibit metabolic adaptations to comply with their biosynthetic needs. However, metabolites also play an important role in supporting cell survival in challenging environments or remodelling the tumour microenvironment, thus being recognized as a hallmark in cancer. Prostate cancer is uniquely driven by androgen receptor signalling, and this knowledge has also influenced the paths of cancer metabolism research. This review provides a comprehensive perspective on the metabolic adaptations that support prostate cancer progression beyond androgen signalling, with a particular focus on tumour cell intrinsic and extrinsic pathways.
引用
收藏
页码:1250 / 1262
页数:13
相关论文
共 50 条
  • [21] METABOLIC SYNDROME AND PROSTATE CANCER: A POSSIBLE LINK TO PROSTATE CANCER AGGRESSIVENESS
    De Nunzio, C.
    Freedland, S. J.
    Miano, R.
    Trucchi, A.
    Cantiani, A.
    Esperto, F.
    Brassetti, A.
    Tubaro, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 116 - 116
  • [22] Tamoxifen induces metabolic adaptations leading to radioresistance in breast cancer
    Naumann, F.
    Adema, G.
    Sweep, F.
    Bussink, J.
    Span, P.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S372 - S373
  • [23] Metabolic Risk Factors in Prostate Cancer
    Chu, David I.
    Freedland, Stephen J.
    CANCER, 2011, 117 (10) : 2020 - 2023
  • [24] Metabolic Syndrome and Prostate Cancer: A Review
    Nobes, J. P.
    Langley, S. E. M.
    Laing, R. W.
    CLINICAL ONCOLOGY, 2009, 21 (03) : 183 - 191
  • [25] Prostate cancer is associated with the metabolic syndrome
    Yaturu, Subhashini
    Fort, Charlton
    JOURNAL OF MENS HEALTH, 2009, 6 (02) : 125 - 129
  • [26] Metabolic imbalance and prostate cancer progression
    Burton, Anya J.
    Tilling, Kate M.
    Holly, Jeff M.
    Hamdy, Freddie C.
    Rowlands, Mari-Anne E.
    Donovan, Jenny L.
    Martin, Richard M.
    INTERNATIONAL JOURNAL OF MOLECULAR EPIDEMIOLOGY AND GENETICS, 2010, 1 (04): : 248 - +
  • [27] Metabolic Alterations in Renal and Prostate Cancer
    Ciccarese, Chiara
    Santoni, Matteo
    Massari, Francesco
    Modena, Alessandra
    Piva, Francesco
    Conti, Alessandro
    Mazzucchelli, Roberta
    Cheng, Liang
    Lopez-Beltran, Antonio
    Scarpelli, Marina
    Tortora, Giampaolo
    Montironi, Rodolfo
    CURRENT DRUG METABOLISM, 2016, 17 (02) : 150 - 155
  • [28] Metabolic adaptations in cancer stem cells: A key to therapy resistance
    Masoudi, Matthew
    Moti, Dilpreet
    Masoudi, Raha
    Auwal, Abdul
    Hossain, M. Matakabbir
    Pronoy, Tasfik Ul Haque
    Rashel, Khan Mohammad
    Gopalan, Vinod
    Islam, Farhadul
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (05):
  • [29] Metabolic syndrome and prostate cancer treatment
    Morlacco, Alessandro
    Zattoni, Fabio
    Soligo, Matteo
    Lami, Valeria
    Iafrate, Massimo
    Zanovello, Nicola
    Dal Moro, Fabrizio
    PANMINERVA MEDICA, 2022, 64 (03) : 359 - 364
  • [30] Obesity, metabolic syndrome, and prostate cancer
    Hsing, Ann W.
    Sakoda, Lori C.
    Chua, Streamson C., Jr.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 86 (03): : 843S - 857S